Repeated pregnancy loss deserves its own assessment. Becoming pregnant and maintaining a pregnancy involve related but different questions, so the workup is not identical to an initial infertility evaluation.
The aim is to identify conditions that could change care while recognizing that a clear cause is not always found.
When should repeated losses be evaluated?
After two pregnancy losses, it is reasonable to discuss an evaluation. Current ASRM guidance includes very early biochemical losses, sometimes called chemical pregnancies, in its definition of recurrent pregnancy loss.
Confirmed ectopic and molar pregnancies are excluded from that definition and require their own assessment. The timing and documentation of each pregnancy help guide the review.
What can cause miscarriage?
Chromosome abnormalities in an embryo are a common cause of pregnancy loss and become more frequent with increasing egg age.
Other relevant findings can include certain uterine abnormalities, antiphospholipid syndrome, and endocrine conditions. In selected families, a parent’s chromosome rearrangement may affect reproductive counseling.
A history of loss does not mean that every abnormal test result explains it. Some patients have no identifiable cause despite an appropriate evaluation.
What does the assessment include?
Start with the details of each pregnancy: positive tests, ultrasound findings, gestational timing, any tissue testing, and treatment received.
Depending on the history, the assessment may include uterine imaging, selected blood tests, review of thyroid function and other medical conditions, and genetic evaluation when appropriate.
Current ASRM guidance recommends offering chromosome testing of miscarriage tissue at a second loss or with an established history of recurrent loss, when tissue can be obtained. It may help explain that particular loss. Results should be interpreted carefully, including limitations such as sample contamination. Testing of either parent is selected according to the findings and history.
Are clotting or immune tests always needed?
No. Antiphospholipid syndrome is different from inherited thrombophilias. Broad inherited-clotting panels or immune testing are not automatically indicated for every patient with repeated miscarriage.
A personal or family history of thrombosis or other clinical findings may change the assessment. Aspirin, blood thinners, or immune treatments should have a specific rationale rather than being added routinely.
What treatments can help?
Treatment depends on the diagnosis. It may involve managing an endocrine condition, addressing a relevant uterine finding, or using an established treatment for confirmed antiphospholipid syndrome.
Genetic counseling may help when a chromosome rearrangement is identified. IVF with appropriate testing can be discussed in selected circumstances, but routine PGT-A has not been shown to improve live birth for everyone with recurrent loss.
Progesterone may be considered in particular situations; it is not a universal answer for every loss history.
What if no cause is found?
An unexplained result does not mean nothing can be done. Counseling can address prognosis, preconception health, and a plan for early monitoring in the next pregnancy.
The outlook depends on age, the pregnancy history, and other findings. A diagnosis of recurrent loss does not mean that every future pregnancy will end in miscarriage.
Plan the next pregnancy with Dr. Arnold
Dr. Arnold Mahesan reviews the sequence of losses and existing investigations to help identify useful next steps and avoid repeating tests without a clear purpose.

By Dr. Arnold Mahesan
Fertility SpecialistBeverly Hills Babies
Dr. Arnold Mahesan is a board-certified fertility specialist with extensive experience in IVF, fertility treatment, and gestational surrogacy. He is committed to helping intended parents navigate their journey with personalized care and expert guidance.

